CIK 0001157601
- Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $6,669,998
- in 2 filings, $6.7M under 10b5-1 plans
Net +$28,353,034. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-15 | BATE KENNETH Director | Sale | −2,567 | $365.33 | $938K | 5,227 |
| 2025-08-15 | BATE KENNETH Director | Sale | −600 | $366.14 | $220K | 4,627 |
| 2025-08-15 | BATE KENNETH Director | Sale | −1,104 | $367.63 | $406K | 3,523 |
| 2025-08-15 | BATE KENNETH Director | Sale | −896 | $368.56 | $330K | 2,627 |
| 2025-08-15 | BATE KENNETH Director | Option exercise · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2025-06-20 | BATE KENNETH Director | Grant or award | +715 | 2,627 | ||
| 2025-06-20 | BATE KENNETH Director | Grant or award · Stock Option (Right to Buy) | +1,290 | 1,290 | ||
| 2025-02-27 | BATE KENNETH Director | Option exercise | +6,000 | $111.06 | $666K | 7,912 |
| 2025-02-27 | BATE KENNETH Director | Option exercise | +9,470 | $65.06 | $616K | 17,382 |
| 2025-02-27 | BATE KENNETH Director | Option exercise | +4,530 | $9.45 | $43K | 21,912 |
| 2025-02-27 | BATE KENNETH Director | Sale | −100 | $351.01 | $35K | 21,812 |
| 2025-02-27 | BATE KENNETH Director | Sale | −500 | $351.99 | $176K | 21,312 |
| 2025-02-27 | BATE KENNETH Director | Sale | −238 | $353.83 | $84K | 21,074 |
| 2025-02-27 | BATE KENNETH Director | Sale | −8,545 | $355.08 | $3.0M | 12,529 |
| 2025-02-27 | BATE KENNETH Director | Sale | −2,791 | $356.51 | $995K | 9,738 |
| 2025-02-27 | BATE KENNETH Director | Sale | −2,038 | $357.27 | $728K | 7,700 |
| 2025-02-27 | BATE KENNETH Director | Sale | −3,548 | $358.33 | $1.3M | 4,152 |
| 2025-02-27 | BATE KENNETH Director | Sale | −2,024 | $359.21 | $727K | 2,128 |
| 2025-02-27 | BATE KENNETH Director | Sale | −216 | $360.07 | $78K | 1,912 |
| 2025-02-27 | BATE KENNETH Director | Option exercise · Stock Option (Right to Buy) | −6,000 | 0 |
Page 2 of 4 · 78 trades